T501-0407 Screening compound: N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carboxamide

T501-0407 Screening compound: N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carboxamide
T501-0407 Screening compound: N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T501-0407
N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T501-0407

Molecular Formula

C20H29N5O (C20 H29 N5 O)

Compound Name

N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carboxamide

IUPAC name

N-(2-phenylethyl)-3-{[4-(propan-2-yl)-4H-124-triazol-3-yl]methyl}piperidine-1-carboxamide

SMILES

CC(C)n1c(CC(CCC2)CN2C(NCCc2ccccc2)=O)nnc1

InChI

InChI=1S/C20H29N5O/c1-16(2)25-15-22-23-19(25)13-18-9-6-12-24(14-18)20(26)21-11-10-17-7-4-3-5-8-17/h3-5,7-8,15-16,18H,6,9-14H2,1-2H3,(H,21,26)/t18-/m1/s1

InChI Key

PDTWBYRYRDKBCT-GOSISDBHSA-N

MDL Number (MFCD)

MFCD31982784

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

355.48

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.665

Distribution Coefficient, logD

2.664

Water Solubility, LogSw

-3.00

Polar Surface Area

52.928

Acid Dissociation Constant (pKa)

15.89

Base Dissociation Constant (pKb)

4.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.00

T501-0407 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T501-0407 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T501-0407?
Check Price and Availability of T501-0407, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T501-0407 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T501-0407
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T501-0407
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T501-0407 available by request